hotspot -WSS

hotspot

author：leisure time 2025-09-04 04:27:08 - browse：31

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Abortion pill case raises question: who can sue the FDA?

WSS

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Primary care physicians play key roles in Alzheimer's management

Arc Institute generative AI designs new CRISPR systems

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Food as medicine: Medically tailored meals may get standardized

NVIDIA and Google execs on the future of AI and drug discovery

leisure time

hotspot

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Anxious about a speech? A startup wants you to pop a minty cardiac drug

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Malaria cases in Florida and Texas: Here’s what you need to know

It's time to retire 'poor historian' from clinicians' vocabularies

Medicare proposal to cover medical devices draws a mixed reaction

States should stop sabotaging methadone treatment reform

hotspot

Glen Campbell's doctor discusses his public struggle with Alzheimer's

With measles on the rise, a personal story of a devastating disease

Wearables generate powerful data but its not useful to doctors, yet

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Addiction experts warn against a second 'war on drugs'

With measles on the rise, a personal story of a devastating disease

knowledge

explore

hotspot

Wikipedia